CIK 0000849146 · Accelerated filer<br>Smaller reporting company
Lifevantage Corp
Sign in to watch- Ticker
- LFVN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 900224471
- Phone
- 801-432-9000
- Business address
- 3300 TRIUMPH BLVD, SUITE 700, LEHI, UT, 84043
- Former names
- LIFELINE THERAPEUTICS, INC., YAAK RIVER RESOURCES INC
- Open-market buys, last 90 days
- $6,071
- in 1 filing
- Open-market sales, last 90 days
- $55,649
- in 1 filing
Net −$49,578. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-01 | Cunningham Kristen Chief Sales Officer | Option exercise · Performance Restricted Stock Units | −3,001 | 6,001 | ||
| 2025-01-01 | Aure Carl Chief Financial Officer | Option exercise | +2,401 | 135,675 | ||
| 2025-01-01 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −3,269 | $17.53 | $57K | 132,406 |
| 2025-01-01 | Aure Carl Chief Financial Officer | Option exercise · Performance Restricted Stock Units | −2,401 | 4,802 | ||
| 2025-01-01 | Neufeld Alissa General Counsel | Option exercise | +2,668 | 94,990 | ||
| 2025-01-01 | Neufeld Alissa General Counsel | Shares withheld for taxes | −3,157 | $17.53 | $55K | 91,833 |
| 2025-01-01 | Neufeld Alissa General Counsel | Option exercise · Performance Restricted Stock Units | −2,668 | 5,334 | ||
| 2024-12-16 | Lewis Darwin Director | Purchase | +227 | $16.00 | $4K | 116,388 |
| 2024-12-12 | BEINDORFF MICHAEL A Director | Gift | −17,185 | 26,983 | ||
| 2024-12-12 | BEINDORFF MICHAEL A Director | Gift | +17,185 | 91,413 | ||
| 2024-11-12 | Aure Carl Chief Financial Officer | Shares withheld for taxes | −5,472 | $13.74 | $75K | 133,274 |
| 2024-11-07 | Latham Cynthia Director | Grant or award | +7,819 | $13.43 | $105K | 55,798 |
| 2024-11-07 | Greer Raymond B Director | Grant or award | +7,819 | $13.43 | $105K | 107,288 |
| 2024-11-07 | Dayton Judd Director | Grant or award | +7,819 | $13.43 | $105K | 33,631 |
| 2024-11-07 | BEINDORFF MICHAEL A Director | Grant or award | +7,819 | $13.43 | $105K | 50,018 |
| 2024-11-07 | Anbalagan Rajendran Director | Grant or award | +7,819 | $13.43 | $105K | 10,468 |
| 2024-11-07 | Mauro Garry Paul Director | Grant or award | +7,819 | $13.43 | $105K | 85,486 |
| 2024-11-07 | Lewis Darwin Director | Grant or award | +7,819 | $13.43 | $105K | 116,161 |
| 2024-11-06 | Fife Steven R President and CEO | Shares withheld for taxes | −38,661 | $13.94 | $539K | 676,442 |
| 2024-10-01 | Neufeld Alissa General Counsel | Option exercise | +2,667 | 95,124 |
Page 8 of 10 · 193 trades